Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.0086 | 0.9 |
mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.9 |
mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.9 |